5.3 People with aphasia more than three months post onset of stroke should be offered intensive/high dose speech and language therapy if they can tolerate it.
Reference: Brady et al., 2016: Cochrane review; The RELEASE collaborators, 2022b: Meta-analysis 25 RCTs (959 IPD)
NHMRC level of Evidence: I
Rationale: The results of a Cochrane review (Brady et al., 2016) suggested a benefit of intensive/high dose over non-intensive/low dose speech and language therapy on measures of functional communication. However, there was a significantly higher dropout rate from high dose/high intensity intervention, particularly in studies recruiting participants within 3 months of aphasia onset.
In The RELEASE group meta-synthesis of individual participant data (n= 959 IPD; 25 RCTs; The RELEASE collaborators, 2022b) subgroup analyses revealed that study participants who were less than or equal to 3 months after stroke onset showed their best language gains from therapy provided less than or equal to 2 hours per week (n=62 IPD; 2 RCTs), 3-5 days per week (n=3 IPD; 1 RCT), and from 20 to 50 hours total (n=27 IPD; 3 RCTs). For participants more than 3 months after stroke onset greatest gains followed 3-4 hours per week (n=25 IPD; 2 RCTs), 5 days per week (n= 44 IPD; 1 RCT), for equal to or more than 50 hours of therapy) n=15 IPD; 1 RCT). However, caution is required in interpreting this finding given the low numbers of IPD/RCTs in these specific subgroup analyses.
![]() | aphasiacre@latrobe.edu.au |
![]() | +61 3 9479 5559 |
![]() | Professor Miranda Rose |